Medicine for cancer therapy containing a lactoferrin hydrolysate and antibody

摘要

Disclosed is a drug combination for an antibody therapy of cancer, which comprises a lactoferrin hydrolysate that is obtained by hydrolyzing lactoferrin with pepsin, an antibody drug and a complement as active ingredients. Further disclosed is the use of such a lactoferrin hydrolysate for the production of a drug combination for enhancing cytotoxic activity of an antibody drug in an antibody therapy of cancer.